Panoutsopoulou, K., Avgeris, M., Magkou, P., Mavridis, K., Dreyer, T., Dorn, J., . . . Scorilas, A. (2020). miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients. International Journal of Cancer, 147(12), 3560-3573. https://doi.org/10.1002/ijc.33182
Citace podle Chicago (17th ed.)Panoutsopoulou, Konstantina, et al. "MiR‐181a Overexpression Predicts the Poor Treatment Response and Early‐progression of Serous Ovarian Cancer Patients." International Journal of Cancer 147, no. 12 (2020): 3560-3573. https://doi.org/10.1002/ijc.33182.
Citace podle MLA (9th ed.)Panoutsopoulou, Konstantina, et al. "MiR‐181a Overexpression Predicts the Poor Treatment Response and Early‐progression of Serous Ovarian Cancer Patients." International Journal of Cancer, vol. 147, no. 12, 2020, pp. 3560-3573, https://doi.org/10.1002/ijc.33182.